[go: up one dir, main page]

DE2035905A1 - Imidazole compounds and their manufacturing process - Google Patents

Imidazole compounds and their manufacturing process

Info

Publication number
DE2035905A1
DE2035905A1 DE19702035905 DE2035905A DE2035905A1 DE 2035905 A1 DE2035905 A1 DE 2035905A1 DE 19702035905 DE19702035905 DE 19702035905 DE 2035905 A DE2035905 A DE 2035905A DE 2035905 A1 DE2035905 A1 DE 2035905A1
Authority
DE
Germany
Prior art keywords
water
nitro
methyl
substituent
iso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702035905
Other languages
German (de)
Inventor
Eduard Dipl.-Chem. Dr.; Peppmöller Reinmar Dipl.-Chem. Dr.; 4150Krefeld. C07d 91-62 Barthell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stockhausen GmbH and Co KG
Original Assignee
Chemische Fabrik Stockhausen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemische Fabrik Stockhausen GmbH filed Critical Chemische Fabrik Stockhausen GmbH
Priority to DE19702035905 priority Critical patent/DE2035905A1/en
Priority to FR7126356A priority patent/FR2103069A5/en
Publication of DE2035905A1 publication Critical patent/DE2035905A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/95Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

203590S203590S

CHEMISCHE FABRIK STOCKHAUSEN & CIE. KREFELDCHEMICAL FACTORY STOCKHAUSEN & CIE. KREFELD

Chemische Fabrik Stockhausen & Cie. · 415 Krefeld · Postfach 570 Chemical factory Stockhausen & Cie. 415 Krefeld P.O. Box 570

"Imidazolverbindungen und deren Herstellungsverfahren""Imidazole compounds and their manufacturing process"

PATENT-ABTEILUNGPATENT DEPARTMENT

Ihre Zeichen Ihre Nachricht vom Unser Zeichen Tetefon-Durchwahl DatumYour reference Your message from our reference T-telephone extension date

Kl/Da 338- 459 l6.Juli 1970Kl / Da 338- 459 July 6, 1970

1,2-disubstituierte 5~Nitro-imidazole zeigen sowohl bakterizide als auch fungizide Wirkung(Niederl.P. 6 503 442 (1965)5 Science 162,1146 (1968); Ind.P.P. 74 212 und 72 522; D.P.(DDR) 42 882).1,2-disubstituted 5-nitro-imidazoles show both bactericidal and fungicidal effects (Niederl.P. 6 503 442 (1965) 5 Science 162 , 1146 (1968); Ind.PP 74 212 and 72 522; DP (DDR) 42 882).

Die Herstellung entsprechender Derivate ist daher einerseits von Interesse, stößt jedoch andererseits auf erhebliche präparative Schwierigkeiten: Die bekannten Synthesen zur Herstellung solcher Nitroimidazolderivate sind zeitraubend und verlaufen meist mit Mäßigen Ausbeuten.The preparation of the corresponding derivatives is therefore of interest on the one hand, but on the other hand encounters considerable preparative difficulties: the known syntheses for preparation Such nitroimidazole derivatives are time-consuming and usually run with moderate yields.

In der deutschen Offenlegungsschrift 1 470 079 werden nun l-Alkyl-2-(ß-aryl-vinyl)-5-nitroimidazole beschrieben, die aus | der Kondensation von l-Alkyl-2-raethyl-5-»itro-imidazol mit aromatischen Aldehyden in Gegenwart eines alkalischen Kondensationsmittels hervorgehen. Da das beschriebene Verfahren wegen der scharfen Reaktionsbedingungen Verharzungen und Zersetzungen der Reaktionspartner hervorruft, ist die Zahl der aromatischen Aldehyde begrenzt auf Benzaldehyd, Furfurol, Halogenbenzaldehyd und Methylbenzaldehyd.In the German Offenlegungsschrift 1 470 079 are now l-Alkyl-2- (ß-aryl-vinyl) -5-nitroimidazoles described, which from | the condensation of 1-alkyl-2-raethyl-5- »itro-imidazole with aromatic aldehydes in the presence of an alkaline condensing agent. Since the procedure described because of the severe reaction conditions resinification and decomposition of the Causes reaction partner, the number of aromatic aldehydes is limited to benzaldehyde, furfural, halobenzaldehyde and methylbenzaldehyde.

Dadurch entstehen aber Verbindungen, die in Wasser gänzlich unlöslich bzw· bei Vorliegen einer Hydroxyalkylgruppe in !-Stellung nur äuaserst minimal löslich sind. Beim Umsatz aromatischer Aldehyde mit hydrophilen Substitueaten wie Hydroxyl- und Aminogruppen bleibt dagegen die Kondensation au·. Säurefunktionen würden den basischen Reaktionskatalysator abfangenThis creates connections that are completely in water insoluble or, if a hydroxyalkyl group is present in the! -position, are only extremely minimally soluble. When converting aromatic aldehydes with hydrophilic substituents such as hydroxyl and Amino groups, on the other hand, do not condense. Acid functions would intercept the basic reaction catalyst

109886/1820109886/1820

-©► «t« 0953800 · V 3381 · if* Tetrapol Krefeld · Bäkerpfid 25 ■ Station: Krefeld Hbf. · BahnantchluS: Krlb«- © ► «t« 0953800 · V 3381 · if * Tetrapol Krefeld · Bäkerpfid 25 ■ Station: Krefeld Hbf.

CHEMISCHE FABRIK STOCKHAÜSEN & CIE. - 2 - KREFELD ,16,7.1970 BlattCHEMICAL FACTORY STOCKHAÜSEN & CIE. - 2 - KREFELD, July 16, 1970 sheet

Imidazolverbindungen und deren HerstellungsverfahrenImidazole compounds and their manufacturing process

und von dieser Seite eine Umsetzung unmöglich machen.and make implementation impossible from this side.

Es wurde nun gefunden, daß man Verbindungen mit besserer Wasserlöslichkeit erhält, wenn man !-substituiertes 2-Methyl-5-nitro-imidazol mit heterocyclischen fünf- und sechsgliedrigen aromatischen Aldehyden umsetzt, wobei mit Stickstoff als Ringheteroatom die stärkste Hydrophilie erzielt wird. Auch isocyclisch^ aromatische Aldehyde sind als Reaktionspartner geeignet, sofern sie mindestens einen Substituenten tragen, der eine hydrophile Funktion besitzt oder in eine solche umgewandelt werden kann.It has now been found that compounds with better water solubility are obtained if! -Substituted 2-methyl-5-nitro-imidazole is reacted with heterocyclic five- and six-membered aromatic aldehydes, with nitrogen being used as Ring heteroatom the strongest hydrophilicity is achieved. Isocyclic ^ aromatic aldehydes are also reactants suitable, provided they carry at least one substituent which has a hydrophilic function or can be converted into one.

Der Reaktionsablauf kann durch folgendes FormeIbiId wiedergegeben werdensThe course of the reaction can be shown by the following form

K-tert.-butylatK-tert-butoxide

worin bedeuten:where mean:

R1 aliphatischer, iso-raid heterocycloaliphatischer, araliphatischer, iso- und feeteroeyelischer aromatischer RestR 1 aliphatic, iso-raid heterocycloaliphatic, araliphatic, iso- and feeteroeyelic aromatic radical

R4 m isocyclischer aromatischer Rest Mit mindestens einem Sub-2R 4 m isocyclic aromatic radical With at least one sub-2

stituenten, der in eine hydrophil® Funktion umgewandeltsubstituent, which is converted into a hydrophil® function werde» kann oder heterocyclisch®:!· aromatischer Heat ©tee/ mit gleicher Substituentemart»become »can or heterocyclic®:! · aromatic Heat © tea / with the same type of substituent »

Die Erfindung sei durch die naeltf®lg»d«ii Beispiel· näher ireranschaulicht, erfährt jedoch damit keine Begrenasamg.The invention is illustrated in more detail by the naeltf®lg "d" ii example, but does not experience any limitation.

109086/1820109086/1820

CHEMISCHE EABRIK STOCKHAUSEN & CIE. -3- KREFELD ,16.7.1970 -J*rtt.CHEMICAL FACTORY STOCKHAUSEN & CIE. -3- KREFELD, July 16, 1970 -J * rtt.

Imidazo!verbindungen und deren HerstellungsverfahrenImidazo! Compounds and their production method

Beispiel 1;Example 1;

1-(l-Methyl-5-nitro-2-imidazolyl)-2-(3-methoxyphenyl)-äthylent Es werden1- (1-methyl-5-nitro-2-imidazolyl) -2- (3-methoxyphenyl) -ethylent It will

2,35 g l,2-Dimethyl-5-nitro-imidazol,2.35 g of 1,2-dimethyl-5-nitro-imidazole, 5j 50 g Kalium-1ert.-butylat und5j 50 g of potassium 1-tert.-butylate and

2,28 g 3-Methoxy-benzaldehyd in 30 ml abs. Äthanol gelöst und 7 Stunden lang bei Zimmertemperatur gerührt. Danach wird der gelbe Niederschlag abfiltriert und aus Methanol umkristallisiert. Nach den Trocknen werden 1,0 g l-(l-Methyl-5-nitro-2-imidazolyl)-2-(3-«ethoxy-phenyl)-ethylen mit einem Schmelzpunkt von 155°C erhalten (23,O# d.TlW),2.28 g of 3-methoxy-benzaldehyde in 30 ml of abs. Dissolved ethanol and stirred for 7 hours at room temperature. The yellow precipitate is then filtered off and recrystallized from methanol. After drying, 1.0 g of 1- (1-methyl-5-nitro-2-imidazolyl) -2- (3- «ethoxyphenyl) -ethylene with a melting point of 155.degree. C. are obtained received (23, O # d.TlW),

Beispiel 2:Example 2:

1- (l-Methyl-5-nitro-2-inidazblyl) -2- (4-cyan-phenyl) -ethylen: 2,35 g l,2-Dinethyl-5-nitro-ifflidazol und 5»50 g Kalium-tert.-butylat werden zusammen nit 2,19 g p-Cyanbenzaldehyd in 30 ml abs. Äthanol gelöst und 7 Stunden bei Raumtemperatur gerührt. Danach wird der gelbe Niederschlag abgesaugt und mit Wasser gewaschen. Es werden 3«2g 1-(l-Methyl-5-nitro-2-inidazolyl)-2-(4-cyan-phenyl)-ethylen nit einen Schmelzpunkt von 291°C erhalten ( 75«5# d.Th.).1- (l-Methyl-5-nitro-2-inidazblyl) -2- (4-cyano-phenyl) -ethylene: 2.35 g of 1,2-dinethyl-5-nitro-ifflidazole and 5 »50 g of potassium tert-butoxide are added together 2.19 g of p-cyanobenzaldehyde in 30 ml of abs. Dissolved ethanol and stirred for 7 hours at room temperature. The yellow precipitate is then filtered off with suction and washed with water. There are 3 «2g 1- (1-methyl-5-nitro-2-inidazolyl) -2- (4-cyano-phenyl) -ethylene nit obtained a melting point of 291 ° C (75 «5 # of theory).

Beispiel 3ιExample 3ι

1-(l-Methyl-5-nitro-2-inidazolyl)-2-(2^thienyl)-8thylen.1- (1-methyl-5-nitro-2-inidazolyl) -2- (2 ^ thienyl) -8thylene.

2,35 g l,2-Din«thyl-5-nitro->inidazol,2.35 g of 1,2-dinethyl-5-nitro-> inidazole, 5,50 g Kalium-tert.-butylat und5.50 g of potassium tert-butoxide and

1,90 g 2-Fomyl-thiophen (Thiophen-2-aldehyd) werden in 30 nl abs. Äthanol gelöst und 7 Stunden bei Raumtemperatur gerührt. Danach wird die Mischung auf O°abgekühlt, der Niederschlag abfiltriert und nit Wasser gewaschen. Man erhält 2,5g l-(l~Methyl-5-nitro-2-inidazolyl)-2-(2-thienyl)-ethylen nit einen Schmelzpunkt von 196°C ( 63,7Ji d.Th.).1.90 g of 2-fomyl-thiophene (thiophene-2-aldehyde) are in 30 nl abs. Dissolved ethanol and stirred for 7 hours at room temperature. The mixture is then cooled to 0 °, the precipitate is filtered off and washed with water. 2.5 g are obtained 1- (1- methyl-5-nitro-2-inidazolyl) -2- (2-thienyl) -ethylene nit a melting point of 196 ° C (63.7 Ji of theory).

109886/1820109886/1820

CHEMISCHE FABRIK STOCKHAUSEN & CIE. KREI=ELD ,16.7.1970 Β'"«CHEMICAL FACTORY STOCKHAUSEN & CIE. KREI = ELD, July 16, 1970 Β '"«

«* if-- Imidasolverbindungen rand deren«* If-- Imidasolverbindungen rand their

Herstellungsverfahrenproduction method

Beispiel kl Example kl

1- (1 -Methyl-^-nitro-^-imidazoly-l )«2- (2-pyridyl) -äthylen. Es werden 30 ml abs. Äthanol nacheinander mit 2,35 g l,2-Dimethyl-5-»itro-iniidazol, 5,00 g Kalium-tert.-butylat und1- (1 -Methyl - ^ - nitro - ^ - imidazoly-1) «2- (2-pyridyl) ethylene. There are 30 ml of abs. With ethanol one after the other 2.35 g of 1,2-dimethyl-5- »itro-iniidazole, 5.00 g of potassium tert-butoxide and

1,80 g Of -Picolin-aldehyd versetzt«1.80 g of picoline aldehyde added «

Nach 7-stündigem Rühren wird auf 0 abgekühlt und der grau-grüne Niederschlag abfiltriert. Zur Reinigung wird die Masse in Methanol gelöst und wiederum mit Wasser gefällt. Man erhält 1,0 g l-(l-Methyl-5-nitro-2-imidazolyl)-2~(2~pyridyl)-äthylen. mit einem Schmelzpunkt von 210-212°C ( 25,9% d.Th.).After stirring for 7 hours, the mixture is cooled to 0 and the gray-green precipitate is filtered off. For cleaning, the mass is in methanol dissolved and again precipitated with water. 1.0 g is obtained 1- (1-methyl-5-nitro-2-imidazolyl) -2- (2- pyridyl) -ethylene. with a melting point of 210-212 ° C (25.9% of theory).

Beispiel 5;Example 5;

3,00 g l-(l-Methyl-5~nitro-2-imidazolyl-2-(4-cyan-phenyl)-äthylen werden mit 3»5 ml konzentrierter Schwefelsäure, die mit 2,1 ml Wasser versetzt wurden, 30 Minuten zum Sieden erhitzt, anschließend abgekühlt und in Wasser gegossen. Der Niederschlag wird abfiltriert, getrocknet und mit heißem Dioxan extrahiert. Der Rückstand besteht aus praktisch reinem 1- (1 -Methyl-5-nitro-Sl-imidazolyl) -2- ( 4-carboxy-phenyl)-äthylen mit einem Schmelzpunkt von 308-3090C (Ausbeute 97% d.Th.).3.00 g of l- (l-methyl-5-nitro-2-imidazolyl-2- (4-cyano-phenyl) -ethylene are mixed with 3 »5 ml of concentrated sulfuric acid, to which 2.1 ml of water have been added, 30 Heated to boiling minutes, then cooled and poured into water. The precipitate is filtered off, dried and extracted with hot dioxane. The residue consists of practically pure 1- (1-methyl-5-nitro-S1-imidazolyl) -2- (4 -carboxy-phenyl) -ethylene with a melting point of 308-309 0 C (yield 97% of theory).

109886/18 20109886/18 20

Claims (2)

CHEMISCHE PABRIK STOGKHAUSEN & CIE, - 5 - KREFELD,l6.7.I97O bU Pat e ntansprü c heCHEMISCHE PABRIK STOGKHAUSEN & CIE, - 5 - KREFELD, July 16, I97O bU Patents claims 1) Hydrophile 1,2-disubstituierte 5-Nitro-imidazole der allgemeinen. Formel1) Hydrophilic 1,2-disubstituted 5-nitro-imidazole der general. formula worin R1 bedeutet!wherein R 1 means! aliphatischen, iso-und heterocycloaliphatischer, araiiphatischer, iso-und heterocyclischer aromatischer Rest, dadurch gekennzeichnet, daß R_ einen isocyclischeii aroniati sehen Rest mit wässerlSslichmachenden Subs ti tue η ten oder einen heterocyclisch aromatischen Rest ohne oder mit wasserlöslich machenden Substituenten darstellt.aliphatic, iso- and heterocycloaliphatic, araiiphatic, iso- and heterocyclic aromatic radical, characterized in that R_ is an isocyclischeii aroniati see remainder with water-solubilizing substances or a heterocyclic aromatic radical with or without water-soluble represents making substituents. 2) Verfahren zur Herstellung von Verbindungen nach Anspruch i, dadurch gekennzeichnet, daß man i-substituiertes 2-Me'thyl-5-»itro-imidazo.l mit einem Aldehyd, der mindestens einen in eine hydrophile Form umformbaren Substituenten trägt, in einem stark basischen Reaktionsmedium zur Reaktion bringt2) Process for the preparation of compounds according to claim i, characterized in that i-substituted 2-methyl-5- »itro-imidazo.l with an aldehyde which carries at least one substituent which can be transformed into a hydrophilic form, in a strongly basic reaction medium to react en an ±i2 in eine wasserlöslichmachende Funktion umwandelt.en an ± i 2 is converted into a water-solubilizing function. und anschließend den oder die Substituenten an R„ in einsand then the substituent or substituents on R "in one 109886/1820109886/1820
DE19702035905 1970-07-20 1970-07-20 Imidazole compounds and their manufacturing process Pending DE2035905A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19702035905 DE2035905A1 (en) 1970-07-20 1970-07-20 Imidazole compounds and their manufacturing process
FR7126356A FR2103069A5 (en) 1970-07-20 1971-07-19 Hydrophillic 1,2-substd-5-nitroimidazoles bactericides - and fungicides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702035905 DE2035905A1 (en) 1970-07-20 1970-07-20 Imidazole compounds and their manufacturing process

Publications (1)

Publication Number Publication Date
DE2035905A1 true DE2035905A1 (en) 1972-02-03

Family

ID=5777290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702035905 Pending DE2035905A1 (en) 1970-07-20 1970-07-20 Imidazole compounds and their manufacturing process

Country Status (2)

Country Link
DE (1) DE2035905A1 (en)
FR (1) FR2103069A5 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087536A (en) * 1976-05-04 1978-05-02 The Dow Chemical Company Method for the use of thienylvinylimidazoles as anthelmintics
US4423046A (en) 1982-04-05 1983-12-27 Sterling Drug Inc. Antibacterial and antiprotozoal 1-methyl-5-nitro-2-(2-phenylvinyl)imidazoles
WO2002046166A1 (en) * 2000-12-04 2002-06-13 F. Hoffmann-La Roche Ag Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
US7153874B2 (en) 2003-03-10 2006-12-26 Hoffmann-La Roche Inc. Imidazole derivatives
US8063076B2 (en) 2006-12-21 2011-11-22 Hoffmann-La Roche Inc. Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine
US8293916B2 (en) 2004-06-01 2012-10-23 Hoffmann-La Roche Inc. Diazole derivatives

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087536A (en) * 1976-05-04 1978-05-02 The Dow Chemical Company Method for the use of thienylvinylimidazoles as anthelmintics
US4423046A (en) 1982-04-05 1983-12-27 Sterling Drug Inc. Antibacterial and antiprotozoal 1-methyl-5-nitro-2-(2-phenylvinyl)imidazoles
WO2002046166A1 (en) * 2000-12-04 2002-06-13 F. Hoffmann-La Roche Ag Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
US6927232B2 (en) 2000-12-04 2005-08-09 Hoffman-La Roche Inc. Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
US6972299B2 (en) 2000-12-04 2005-12-06 Hoffmann-La Roche Inc. Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
US7153874B2 (en) 2003-03-10 2006-12-26 Hoffmann-La Roche Inc. Imidazole derivatives
US8293916B2 (en) 2004-06-01 2012-10-23 Hoffmann-La Roche Inc. Diazole derivatives
US8063076B2 (en) 2006-12-21 2011-11-22 Hoffmann-La Roche Inc. Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine
US8329912B2 (en) 2006-12-21 2012-12-11 Hoffmann-La Roche Inc. Solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine

Also Published As

Publication number Publication date
FR2103069A5 (en) 1972-04-07

Similar Documents

Publication Publication Date Title
DE2035905A1 (en) Imidazole compounds and their manufacturing process
DE2006472A1 (en) Furan-3-carboxamide derivatives and processes for their preparation
DE2237632A1 (en) METHOD FOR PREPARING 1- (4-METHYL-6-METHOXY-2-PYRIMIDINYL) -3-METHYL-5METHOXYPYRAZOLE
DE2521966C3 (en) 33-bis- (4-hydroxyphenyl) -7-methyl-2-indolinone derivatives, their salts and processes for their preparation
DE1668385C3 (en) Quaternary semicarbazone and thiosemicarbazone salts, processes for their preparation and these contain de pharmaceutical compositions
DE2345951C2 (en) 1- (2,6-Dichlorophenylamidino) urea or its hydrochloride, process for its production and therapeutic preparation containing it
DE1545666A1 (en) New diazacyloalkane compounds
CH524611A (en) 2-substd-4,5-bis(substd-phenyl) imidazole - analgesics
DE2144077C3 (en) New Hydroxyäthylaminoalkylpiperazines and processes for their preparation
DE3152942T1 (en) HETEROCYCLICALLY SUBSTITUTED AMIDINE UREAS AND THEIR THERAPEUTIC USE
DE2335144A1 (en) BASIC SUBSTITUTED NITROIMIDAZOLE METHYLENAMINO-IMIDAZOLIDINONE
DE1695849A1 (en) Process for the preparation of new pyrimidine derivatives
AT211325B (en) Process for the preparation of hydantoin derivatives
DE2125544C3 (en) 2H, 4H-U.4 Tnazin-33-dione
DE1545672B2 (en) Dicarboximide derivatives and processes for their preparation
DE2127902A1 (en) Process for the preparation of quinoxaline dioxide derivatives
DE1057597B (en) Process for the preparation of aminoguanidines
AT237628B (en) Process for the production of the new 3-phenoxypropylguanidine
DE1593921C3 (en) alpha- (3,4,5-trimethoxybenzyl) -alphaeckige bracket on (N-methyl-N-homoveratryl) -gamma -aminopropyl square bracket on -S ^ .S-trimethoxyphenylacetonitrile and its salts and processes for their preparation and containing these compounds drug
AT214447B (en) Process for the preparation of new trifluoromethyl-benzothiadiazinesulfonamide derivatives
AT288413B (en) Process for the production of new basic xanthone derivatives and their salts
DE1644553A1 (en) Process for the preparation of 2-alkyl- or 2-aryl-methylenequinizarines
DE1770762C3 (en) Substituted 2-amino-hexahydrobenzo [a] quinolizines
AT255422B (en) Process for the preparation of new iminodibenzyl derivatives
DE1445996A1 (en) Benzylpiperidyl ketones